1. Home
  2. OEC vs ELDN Comparison

OEC vs ELDN Comparison

Compare OEC & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion S.A.

OEC

Orion S.A.

HOLD

Current Price

$7.66

Market Cap

319.6M

Sector

Industrials

ML Signal

HOLD

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$3.83

Market Cap

300.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OEC
ELDN
Founded
1862
2004
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
319.6M
300.3M
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
OEC
ELDN
Price
$7.66
$3.83
Analyst Decision
Sell
Strong Buy
Analyst Count
4
2
Target Price
$6.56
$8.50
AVG Volume (30 Days)
420.7K
1.1M
Earning Date
05-06-2026
05-12-2026
Dividend Yield
1.11%
N/A
EPS Growth
N/A
30.67
EPS
N/A
N/A
Revenue
$1,806,700,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.21
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$1.35
52 Week High
$12.10
$4.60

Technical Indicators

Market Signals
Indicator
OEC
ELDN
Relative Strength Index (RSI) 59.14 56.35
Support Level $5.96 $3.35
Resistance Level $8.40 $4.14
Average True Range (ATR) 0.36 0.20
MACD 0.03 -0.02
Stochastic Oscillator 84.39 59.59

Price Performance

Historical Comparison
OEC
ELDN

About OEC Orion S.A.

Orion SA is a manufacturer of carbon black products. Carbon black is a powdered form of carbon used to create the desired physical, electrical, and optical qualities of various materials. The company's operating segments are Specialty Carbon Black and Rubber Carbon Black. It generates maximum revenue from the Rubber Carbon Black segment. The Rubber Carbon Black segment is used in the reinforcement of rubber in tires and mechanical rubber goods. The Specialty Carbon Black segment is used as pigments and performance additives in coatings, polymers, printing, and special applications. Geographically, it derives a majority of its revenue from Germany.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

Share on Social Networks: